Biotage has entered into an agreement to acquire Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences.
The enterprise value for Astrea is approximately 190 million USD, subject to any closing adjustments and potential milestone-based payments, states the c